Table 1 Clinical and laboratory characteristics in patients with and without coronary artery disease
CAD- (n = 34) | CAD + (n = 119) | p value | |
|---|---|---|---|
Age (years) | 59.18 ± 12.25 | 61.76 ± 10.05 | 0.210 |
Male gender, n (%) | 14 (41.1) | 98 (82.3) | <0.001 |
BMI (kg/m2) | 30.74 ± 5.90 | 28.92 ± 3.87 | 0.198 |
Central obesity n (%) | 33 (97.0%) | 118 (99.1%) | 0.791 |
WC (cm) | 100.97 ± 11.81 | 103.47 ± 8.81 | 0.256 |
Waist-hip ratio | 0.92 ± 0.08 | 0.98 ± 0.06 | <0.001 |
Smoking, n (%) | 6 (17.6) | 64 (53.7) | <0.001 |
Diabetes mellitus, n (%) | 13 (38.2) | 65 (54.6) | 0.093 |
Hypertension, n (%) | 26 (76.5) | 85 (71.4) | 0.564 |
Hyperlipidemia, n (%) | 24 (70.5) | 85 (71.4) | 0.924 |
Metabolic syndrome n (%) | 29 (85.2) | 111 (93.2) | 0.141 |
FPG (mg/dl) | 104.0 (95.00-119.25) | 119.5 (97.00-152.25) | 0.076 |
Total cholesterol (mg/dl) | 175.97 ± 41 | 164.94 ± 48.55 | 0.231 |
LDL-C (mg/dl) | 103.85 ± 33.58 | 91.63 ± 37.33 | 0.088 |
HDL-C (mg/dl) | 42.35 ± 11.35 | 35.81 ± 8.94 | 0.003 |
TG (mg/dl) | 141 (106.5-203.5) | 151 (105.0-245.0) | 0.353 |
hsCRP (mg/dl) | 1.08 ± 2.08 | 3.01 ± 5.65 | 0.002 |
Adiponectin (μg/ml) | 11.66 ± 6.77 | 8.88 ± 4.64 | 0.039 |
Fibrinogen (mg/dl) | 547.0 (469.0-660.0) | 591.5 (480.5-744.0) | 0.090 |